Trials / Completed
CompletedNCT03292939
Progestrone and Doppler Indices
The Effect of Vaginal Progestrone on Fetal and Maternal Doppler Indices
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Kasr El Aini Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The aim of our study is to assess the effect of vaginal progestrone on fetal and maternal doppler indices
Detailed description
A complete Doppler flow assessment of the maternal and fetal circulation was conducted by an independent investigator blinded to the treatment, before and 48 hours after the first administration of 400mg of vaginal progesterone, Voluson E8 (GE Healthcare, Zipf, Austria) ultrasound machine,equipped with a 3.5- MHz curvilinear abdominal transducer with color imaging capabilities, was used in all cases.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | A complete Doppler flow assessment of the maternal and fetal circulation | A complete Doppler flow assessment of the maternal and fetal circulation was conducted by an independent investigator blinded to the treatment, 48 hours after receiving 400mg of vaginal progestrone .Voluson E8 (GE Healthcare, Zipf, Austria) ultrasound machine ,equipped with a 3.5-MHz curvilinear abdominal transducer with color imaging capabilities, was used in all cases. |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2017-10-01
- Completion
- 2017-10-01
- First posted
- 2017-09-26
- Last updated
- 2017-10-11
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03292939. Inclusion in this directory is not an endorsement.